Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists unlock solid tumor treatment genetic secrets

05.12.2005


Study suggests that histone deacetylase enzymes cooperating with CBP/p300 histone acetylases trigger expression of many genes that respond to hypoxia, according to St. Jude



A biochemical mechanism that cells use to cope with hypoxia (lack of oxygen) actually cooperates with a less well-known mechanism that helps increase the expression of those hypoxia-sensitive genes, according to investigators at St. Jude Children’s Research Hospital.

The two mechanisms each enable a transcription factor called hypoxia-inducible factor (HIF) to increase expression of genes that the cell uses to respond to the stress of hypoxia. Transcription factors bind to a site on the gene called the promoter and trigger the process that decodes the gene and makes the protein for which that gene codes. HIF binds to and activates many genes that contribute to the survival response of tumors; for example, genes that control biochemical reactions that don’t require oxygen to extract energy from glucose or genes needed to build new blood vessels that bring additional oxygen to hypoxic cells.


The St. Jude finding is important because it suggests that developing new therapies that interfere with both mechanisms instead of just one might enhance the efficacy of treatments designed for solid tumors that become hypoxic as they outgrow their oxygen supply, according to Paul Brindle, Ph.D., an associate member of the Department of Biochemistry. Brindle is senior author of a report on this work that appeared in November 16 issue of The EMBO Journal.

The St. Jude researchers showed that, in addition to a mechanism controlled by two proteins called CBP and p300 (CBP/p300 collectively), a second mechanism that appears to use an enzyme called a histone deacetylase (HDAC) contributes significantly to increasing the expression of hypoxia-sensitive genes. The investigators also found evidence that suggests HIF might activate genes by a third type of biochemical pathway. If true, this would further expand the range of potential strategies for treating solid tumors.

HIF is unstable and cannot work well when the cell contains a normal amount of oxygen. But when oxygen levels are so low they stress the cell, HIF becomes stable and binds to specific genes. Once on a target gene, HIF recruits CBP and p300, each of which contains a section called the CH1 domain. The CH1 domain of each protein binds to a section of HIF called the C-TAD. This binding of the CH1 domain to the C-TAD prompts HIF to turn on the gene. Because CBP and p300 each help HIF activate genes, they are called co-activators.

CBP and p300 belong to a group of coactivators called acetylases, and have long been thought to bind to HIF during the cell’s response to hypoxia, but definitive evidence for this occurring in cells was previously lacking. In contrast, HDACs were thought to be proteins that interfere with the expression of genes. Unexpectedly, the St. Jude team discovered that a drug-like inhibitor of HDACs called TSA interferes with the ability of HIF to turn on a large number of genes during times of hypoxia. The study further suggests that HDACs appear to cooperate with CBP/p300 to help HIF trigger the expression of most of the approximately 40 HIF responsive genes tested. The study also showed that different HIF-targeted genes rely to various degrees on the CH1 domain and the mechanism sensitive to TSA.

"This finding was surprising because until now it was generally accepted that acetylases are involved in activating genes, while deacetylases were mostly thought to have the opposite effect," Brindle said. "That increases our appreciation for the complexity of the control of HIF-responsive genes. That is important for future studies on how to manipulate these mechanisms to treat diseases linked to hypoxia."

Brindle’s team studied HIF activation in laboratory models that had mutations that eliminated the CH1 domain in either or both of the genes for CBP and p300. The investigators found that certain genes whose activity could be induced by hypoxia were moderately to strongly dependent on the CH1 domain. One of these genes, Vegf, is important for the growth of new blood vessels, while another gene, Slc2a1, is important in bringing glucose into the cell for energy.

In addition, the St. Jude team discovered that some genes continue to be expressed fairly well even when both the CH1 and HDAC mechanisms are disrupted. This suggests that there are other coactivators, or that other domains on CBP and p300 in addition to CH1 work with HIF to activate gene expression. Alternatively, transcription factors other than HIF may mediate part of the response to hypoxia.

"Our study clearly showed that there is more to activating HIF-responsive gene expression than just the previously recognized CBP/p300 mechanism," said Lawryn H. Kasper, Ph.D., a research laboratory specialist in Brindle’s laboratory. "In fact, not only does a mechanism involving HDAC appear to play a major role; but there is also evidence for a completely different pathway." Kasper is the first author of the article and together with her co-worker Fayçal Boussouar, Ph.D., did most of the work on this study.

Carrie Strehlau | EurekAlert!
Further information:
http://www.stjude.org

More articles from Life Sciences:

nachricht What the world's tiniest 'monster truck' reveals
23.08.2017 | American Chemical Society

nachricht Treating arthritis with algae
23.08.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

What the world's tiniest 'monster truck' reveals

23.08.2017 | Life Sciences

Treating arthritis with algae

23.08.2017 | Life Sciences

Witnessing turbulent motion in the atmosphere of a distant star

23.08.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>